ALLISON DOSS: Open Payments
NPI 1194148197 · WYNNE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 8 companies in 2025. Trend: 2023 $425 · 2024 $38 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $50 |
| Braeburn Inc. | 1 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| Insulet Corporation | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: BRIXADI, QUTENZA, TRUMENBA, Omnipod, PREVNAR 20, CAPLYTA, VIVITROL, GARDASIL 9.
Industry payments across AR — which companies pay providers there.
